Table 1.
Patients’ demographics, disease history and data on extent and clinical type of onychomycosis
| Parameter (n = 14) | All patients (n = 33) | Mycology + at study entry (n = 19)1 | Mycology − at study entry (n = 14)1 |
|---|---|---|---|
| Demographics | |||
| Male/female | 17 (52)/16 (48) | 13 (68)/6 (32) | 4 (29)/10 (71) |
| Age (years) | 63 ± 12 [36–80] | 65 ± 14 [37–80] | 60 ± 8 [36–72] |
| Disease history | |||
| <5 years | 6 (18) | 2 (10.5) | 4 (29) |
| 5–10 years | 5 (15) | 2 (10.5) | 3 (21) |
| >10 years | 22 (67) | 15 (79) | 7 (50) |
| Extent of onychomycosis | |||
| Toenails affected | 33 (100) | 19 (100) | 14 (100) |
| Big toe affected | 33 (100) | 19 (100) | 14 (100) |
| Severity of onychomycosis | |||
| Mild | 15 (45) | 7 (37) | 8 (57) |
| Severe | 18 (55) | 12 (63) | 6 (43) |
| Clinical type of onychomycosis | |||
| WSO | 3 (9) | 0 (0) | 3 (21) |
| DLSO | 22 (67) | 13 (68) | 9 (64) |
| TDO | 8 (24) | 6 (32) | 2 (14) |
| Clinical treatment history | |||
| Previous oral antifungal therapy | 7 (21) | 5 (26) | 2 (14) |
| Previous topical therapy | 10 (30) | 4 (21) | 6 (43) |
| Clinical cure among compliant patients | |||
| Data not available | 1 (3) | 1 (5) | 0 (0) |
| No improvement | 18 (55) | 12 (63) | 6 (43) |
| Improvement | 11 (33) | 6 (32) | 5 (36) |
| Complete clinical cure | 3 (9) | 0 (0) | 3 (21) |
Values denote number of patients (percentage) or mean ± standard deviation [range]. WSO, white superficial onychomycosis; DLSO, distal and lateral subungual onychomycosis; TDO, total dystrophic onychomycosis.
1
Mycology + or − denotes mycological culture or potassium hydroxide (KOH) stain positive or negative.